Time to replace the term neuroleptic malignant syndrome with antidopaminergic syndrome?

Lancet Psychiatry. 2022 May;9(5):348. doi: 10.1016/S2215-0366(22)00108-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Humans
  • Neuroleptic Malignant Syndrome* / diagnosis

Substances

  • Antipsychotic Agents